Hondal Francis 4

What Happened
Hondal Francis, a director of Equitable Holdings, reported a grant of 4,400 fully vested common shares on 2026-05-20 valued at $42.05 per share (total $185,020). The filing also discloses a series of small open-market purchases from March 2023 through December 2025 totaling about $45,851. The award (code A) is a fully vested grant under the company’s 2019 Omnibus Incentive Plan; the purchases (code P) are routine open-market buys (a purchase is generally viewed as a more bullish signal than a sale, though no motive is stated).

Key Details

• Transaction dates and prices (open-market purchases; P):
  • 2023-03-06: 66.357 shares @ $31.99 = $2,123
  • 2023-06-12: 89.146 shares @ $26.36 = $2,350
  • 2023-08-14: 83.581 shares @ $28.35 = $2,370
  • 2023-12-04: 122.635 shares @ $30.87 = $3,786
  • 2024-03-04: 112.009 shares @ $34.04 = $3,813
  • 2024-06-10: 103.725 shares @ $40.36 = $4,186
  • 2024-08-13: 109.089 shares @ $38.60 = $4,211
  • 2024-12-03: 88.536 shares @ $47.86 = $4,238
  • 2025-03-12: 85.282 shares @ $49.94 = $4,259
  • 2025-06-09: 88.074 shares @ $54.66 = $4,814
  • 2025-08-12: 91.590 shares @ $52.82 = $4,838
  • 2025-12-01: 103.777 shares @ $46.86 = $4,863
• Award (A): 2026-05-20 — 4,400 shares @ $42.05 = $185,020 (fully vested grant).
• Total value of prior open-market purchases reported here: ≈ $45,851.
• Shares owned after the reported transactions: not specified in the provided filing excerpt.
• Footnotes:
  • F1: Some shares reflect dividend reinvestment plan (DRIP) activity inadvertently administered by the reporting person's broker-dealer and not previously reported. The filing notes these DRIP shares were reported late.
  • F2: The 4,400-share grant is fully vested and exempt under Rule 16b-3.
• Timeliness: The filing (accession filed 2026-05-21; report period includes transactions back to 2023) notes late disclosure for the DRIP shares — the filing is therefore late for some earlier activity.

Context

• The award is a fully vested grant under the company plan and is exempt from short-swing liability under Rule 16b-3; it does not represent an option exercise or an immediate sale.
• The multiple small open-market purchases over 2023–2025 are modest in dollar size and were reported alongside the grant; they may reflect routine buying and/or dividend reinvestment.
• The filing discloses late reporting of some dividend reinvestment shares; late filings can reduce the usefulness of insider-trading signals but do not necessarily imply wrongdoing.

If you want, I can compute cumulative share totals (if you provide prior holdings) or fetch the full Form 4 text to confirm "shares owned following" and any additional disclosures.